Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3389/fpsyt.2017.00165 http://scihub22266oqcxt.onion/10.3389/fpsyt.2017.00165 C5594062!5594062!28936184     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=28936184&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Front+Psychiatry 2017 ; 8 (ä): ä Nephropedia Template TP {{tp|p=28936184|t=2017. Hypothermia due to Antipsychotic Medication: A Systematic Review |pdf=|usr=}}{{28936184}} gab.com Text Hypothermia due to Antipsychotic Medication: A Systematic Review JO: Front Psychiatry http://www.kidney.de/pget.php?&tw=1&pmid=28936184 #FOAvip Background: Hypothermia is a rare, but potentially fatal adverse effect of antipsychotic drug (APD) use. Although the opposite condition, hyperthermia, has been researched extensively in the context of the malignant antipsychotic syndrome, little is known about hypothermia due to APDs. Objective: This study aimed to review the literature on hypothermia in the context of APD use, and formulate implications for research and clinical care. Methods: A systematic search was made in PubMed and Ovid Medline. Results: The literature search yielded 433 articles, including 57 original case descriptions of hypothermia developed during APD use with non-toxic plasma levels. All cases together indicate that the risk of developing hypothermia is highest during the 7?days following initiation, or increase in dosage, of APDs, especially in the presence of additional predisposing factors, such as advanced age, exposure to cold, adjuvant use of benzodiazepines, and (subclinical) hypothyroidism. In addition, data derived from drug-monitoring agencies suggest that the prevalence of APD-related hypothermia is at least 10 times higher than suggested by the literature. Conclusion: We conclude that health-care professionals need to monitor the body temperature of patients starting with (an increased dose of) APDs for a duration of 7?10?days to prevent hypothermia, especially in the presence of multiple risk factors. Moreover, systematic studies are needed to establish the actual prevalence of APD-related hypothermia as well as the relative risk for individual APDs. Twit Text FOAVip Hypothermia due to Antipsychotic Medication: A Systematic Review ????Front Psychiatry http://www.kidney.de/pget.php?&tw=1&pmid=28936184 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28936184 #FOAvip English Wikipedia <ref>{{Cite pmid|28936184}}</ref> Hypothermia due to Antipsychotic Medication: A Systematic Review #MMPMID28936184 Zonnenberg C; Bueno-de-Mesquita JM; Ramlal D; Blom JD Front Psychiatry 2017[]; 8 (ä): ä PMID28936184show ga Background: Hypothermia is a rare, but potentially fatal adverse effect of antipsychotic drug (APD) use. Although the opposite condition, hyperthermia, has been researched extensively in the context of the malignant antipsychotic syndrome, little is known about hypothermia due to APDs. Objective: This study aimed to review the literature on hypothermia in the context of APD use, and formulate implications for research and clinical care. Methods: A systematic search was made in PubMed and Ovid Medline. Results: The literature search yielded 433 articles, including 57 original case descriptions of hypothermia developed during APD use with non-toxic plasma levels. All cases together indicate that the risk of developing hypothermia is highest during the 7?days following initiation, or increase in dosage, of APDs, especially in the presence of additional predisposing factors, such as advanced age, exposure to cold, adjuvant use of benzodiazepines, and (subclinical) hypothyroidism. In addition, data derived from drug-monitoring agencies suggest that the prevalence of APD-related hypothermia is at least 10 times higher than suggested by the literature. Conclusion: We conclude that health-care professionals need to monitor the body temperature of patients starting with (an increased dose of) APDs for a duration of 7?10?days to prevent hypothermia, especially in the presence of multiple risk factors. Moreover, systematic studies are needed to establish the actual prevalence of APD-related hypothermia as well as the relative risk for individual APDs. äHypothermia due to Antipsychotic Medication: A Systematic Review (epmc).pdf DeepDyve Pubget Overpricing